An Unusual Partnership to Tackle Stubborn Diseases
By Gina Kolata (The New York Times) – The National Institutes of Health, 10 large drug companies and seven nonprofit organizations announced an unconventional partnership on Tuesday intended to speed up development of drugs to treat Alzheimer’s disease, Type 2 diabetes, rheumatoid arthritis and lupus.